Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view of different types of thyroid drugs i.e. hypothyroid drugs and hyperthyroid drugs. The report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in the descending order.
A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global thyroid gland disorders treatment market and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, epidemiology study, event impact analysis, regulatory framework and market share analysis by key players (%) operating in the thyroid gland disorders treatment market.
Based on disorders, the global thyroid gland disorders treatment market has been segmented into hypothyroidism and hyperthyroidism. The market for these types has been extensively analyzed for different thyroid gland disorders drugs based on sales revenue of the various generic and branded products developed by the manufacturers. The market size and forecast in terms of USD million for each disorder has been provided for the period from 2013 to 2023. The report on the thyroid gland disorders treatment market also provides with compounded annual growth rate (CAGR %) for each of the market segments mentioned above with the forecast period from 2015 to 2023, considering 2014 as the base year.
Geographically, the thyroid gland disorders treatment market has been categorized into North America, Europe, Asia-Pacific, Latin America, the Middle East and North Africa (MENA) and Rest of the World (RoW) which are further divided based on the disorder types i.e. hypothyroidism and hyperthyroidism. Asia Pacific, further comprises detailed country analysis for China and Rest of APAC. Likewise, Latin America extensively provides with the detailed countrywise analysis for Brazil and Rest of LATAM. The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2015 to 2023. The research study also incorporates the competitive scenario of major players in these regions.
A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of the major players in the thyroid gland disorders treatment market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, Lannett Company, Inc., Pfizer, Inc., Merck KGaA, and Mylan N.V.
The global thyroid gland disorders treatment market is segmented as follows
MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.Get A Free Custom Research Quote